Meeting
2019 Genitourinary Cancers Symposium
Increasing utilization of multi-parametric magnetic resonance imaging in prostate cancer active surveillance.
Authors
Avinash Maganty
University of Pittsburgh Medical Center, Pittsburgh, PA
Avinash Maganty , Michelle Yu , Liam C Macleod , Jonathan G Yabes , Mina M Fam , Jathin Bandari , Robert Turner , Alessandro Furlan , Christopher Paul Filson , Benjamin John Davies , Bruce Lee Jacobs
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, Testicular, and Adrenal Cancers
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 37, 2019 (suppl 7S; abstr 125)
DOI
10.1200/JCO.2019.37.7_suppl.125
Abstract #
125
Poster Bd #
C7
Abstract Disclosures
Similar Posters
Poster
2018 Genitourinary Cancers Symposium
Outcomes of serial MRI/ultrasound fusion targeted biopsy in men with very low-risk and low-risk prostate cancer managed with active surveillance.
First Author: Walter Hsiang
Poster
2023 ASCO Genitourinary Cancers Symposium
“It just makes sense to me”: Patient experiences with prostate MRI during prostate cancer active surveillance.
First Author: Ryan Sutherland
Poster
2022 ASCO Genitourinary Cancers Symposium
Distribution of NCCN risk classifications using MRI-ultrasound fusion versus systematic 12 core biopsies.
First Author: Ghazal Khajir
Poster
2020 Genitourinary Cancers Symposium
Clinical utility of PSA density and PI-RADS for deferring biopsy for the detection of clinically significant prostate cancer.
First Author: Matthew Truong